The evolving epidemiology of paediatric acute mastoiditis in New Zealand.

Publication date: Aug 01, 2025

In 2017, PCV-13 was replaced by PCV-10 in the New Zealand immunisation schedule. The aim of this study was to evaluate the impact of this change on the incidence and microbiology of paediatric acute mastoiditis (AM) in NZ. A retrospective observational study was conducted, including patients aged

Concepts Keywords
Microbiology 13-valent pneumococcal vaccine
Otorhinolaryngol Acute Disease
Retrospective Adolescent
Zealand Child
Child, Preschool
COVID-19
Female
Humans
Incidence
Infant
Male
Mastoiditis
New Zealand
Pneumococcal Infections
Pneumococcal Vaccines
Pneumococcal Vaccines
Retrospective Studies
Streptococcus pneumoniae

Semantics

Type Source Name
disease MESH mastoiditis
drug DRUGBANK Penciclovir
disease MESH Acute Disease
disease MESH COVID-19
disease MESH Pneumococcal Infections

Original Article

(Visited 3 times, 1 visits today)